CareDx: Hannah Valantine
CareDx has appointed Hannah Valantine to its board of directors.
Valantine is a professor of medicine at Stanford and the former NIH CSO for Scientific Workforce Diversity. Prior to joining the NIH, she served as professor of cardiovascular medicine and senior associate dean for diversity and leadership at Stanford. Valantine has partnered with CareDx for several years, including as a principal investigator on publications for the company's AlloMap Heart test, and is one of the researchers behind the original patents for CareDx's AlloSure test.